4.7 Article

Carbonic anhydrase II does not exhibit Nitrite reductase or Nitrous Anhydrase Activity

Journal

FREE RADICAL BIOLOGY AND MEDICINE
Volume 117, Issue -, Pages 1-5

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.freeradbiomed.2018.01.015

Keywords

Carbonic anhydrase II; Nitrite reductase; Nitrite; Nitrous acid; Dinitrogen trioxide; Nitrous anhydrase

Ask authors/readers for more resources

Carbonic anhydrase II (CA II) is a zinc metalloenzyme that catalyzes the reversible interconversion of water and CO2 to bicarbonate and a proton. CA II is abundant in most cells, and plays a role in numerous processes including gas exchange, epithelial ion transport, respiration, extra- and intracellular pH control, and vascular regulation. Beyond these CO2 and pH-linked roles, it has been postulated that CA II might also reduce nitrite (NO2-) to nitric oxide (NO), as bicarbonate and NO2- both exhibit sp(2) molecular geometry and NO also plays an important role in vasodilation and regulation of blood pressure. Indeed, previous studies by Aamand et al. have shown that bovine CA II (BCA II) possesses nitrite dehydration activity and paradoxically demonstrated that CA inhibitors (CAIs) such as dorzolamide and acetazolamide significantly increased NO production (Aamand et al., 2009; Nielsen and Fago, 2015) [1,2]. Hence, the goal of this work was to revisit these studies using the same experimental conditions as Aamand et al. measuring NO generation by two methods, and to examine the structure of CA II in complex with NO2- in the presence and absence of dorzolamide. Our results contradict the previous findings and indicate that CA II does not exhibit nitrite reductase or dehydration activity, and that this is not enhanced in the presence of CA inhibitors. In addition, a structural examination of BCA II in complex with NO2- and superimposed with dorzolamide demonstrates that CA inhibitor binding at the active site to the zinc moiety blocks potential NO2- binding.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Medicinal

Discovery of β-Adrenergic Receptors Blocker-Carbonic Anhydrase Inhibitor Hybrids for Multitargeted Antiglaucoma Therapy

Alessio Nocentini, Mariangela Ceruso, Silvia Bua, Carrie L. Lomelino, Jacob T. Andring, Robert McKenna, Cecilia Lanzi, Silvia Sgambellone, Riccardo Pecori, Rosanna Matucci, Luca Filippi, Paola Gratteri, Fabrizio Carta, Emanuela Masini, Silvia Selleri, Claudiu T. Supuran

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Endocrinology & Metabolism

Characterization of a novel variant in siblings with Asparagine Synthetase Deficiency

Stephanie J. Sacharow, Elizabeth E. Dudenhausen, Carrie L. Lomelino, Lance Rodan, Christelle Moufawad El Achkar, Heather E. Olson, Casie A. Genetti, Pankaj B. Agrawal, Robert McKenna, Michael S. Kilberg

MOLECULAR GENETICS AND METABOLISM (2018)

Review Biochemistry & Molecular Biology

Cancer Drug Development of Carbonic Anhydrase Inhibitors beyond the Active Site

Srishti Singh, Carrie L. Lomelino, Mam Y. Mboge, Susan C. Frost, Robert McKenna

MOLECULES (2018)

Article Chemistry, Medicinal

Sweet Binders: Carbonic Anhydrase IX in Complex with Sucralose

Carrie L. Lomelino, Akilah B. Murray, Claudiu T. Supuran, Robert McKenna

ACS MEDICINAL CHEMISTRY LETTERS (2018)

Article Biochemical Research Methods

Carbonic anhydrase II microcrystals suitable for XFEL studies

Carrie L. Lomelino, Jin Kyun Kim, Cheol Lee, Seon Woo Lim, Jacob T. Andring, Brian P. Mahon, Moses Chung, Chae Un Kim, Robert McKenna

ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2018)

Article Chemistry, Medicinal

4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides Selectively Target the Tumor-Associated Carbonic Anhydrase Isoforms IX and XII Showing Hypoxia-Enhanced Antiproliferative Profiles

Alessio Nocentini, Elena Trallori, Srishti Singh, Carrie L. Lomelino, Gianluca Bartolucci, Lorenzo Di Cesare Mannelli, Carla Ghelardini, Robert McKenna, Paola Gratteri, Claudiu T. Supuran

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Immunology

Next Generation Sequencing of the Pig αβ TCR Repertoire Identifies the Porcine Invariant NKT Cell Receptor

Guan Yang, Bianca L. Artiaga, Carrie L. Lomelino, Anitha D. Jayaprakash, Ravi Sachidanandam, Robert Mckenna, John P. Driver

JOURNAL OF IMMUNOLOGY (2019)

Article Biochemical Research Methods

Carbonic anhydrase II in complex with carboxylic acid-based inhibitors

Carrie L. Lomelino, Robert McKenna

ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2019)

Article Genetics & Heredity

The splicing component ISY1 regulates APE1 in base excision repair

Aruna S. Jaiswal, Elizabeth A. Williamson, Gayathri Srinivasan, Kimi Kong, Carrie L. Lomelino, Robert McKenna, Christi Walter, Patrick Sung, Satya Narayan, Robert Hromas

DNA REPAIR (2020)

Article Chemistry, Medicinal

Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells

Andrea Petreni, Alessandro Bonardi, Carrie Lomelino, Sameh M. Osman, Zeid A. ALOthman, Wagdy M. Eldehna, Radwan El-Haggar, Robert McKenna, Alessio Nocentini, Claudiu T. Supuran

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Chemistry, Medicinal

A Sweet Combination: Developing Saccharin and Acesulfame K Structures for Selectively Targeting the Tumor-Associated Carbonic Anhydrases IX and XII

Silvia Bua, Carrie Lomelino, Akilah B. Murray, Sameh M. Osman, Zeid A. ALOthman, Murat Bozdag, Hatem A. Abdel-Aziz, Wagdy M. Eldehna, Robert McKenna, Alessio Nocentini, Claudiu T. Supuran

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Chemistry, Medicinal

Sulfonamide Inhibitors of Human Carbonic Anhydrases Designed through a Three-Tails Approach: Improving Ligand/Isoform Matching and Selectivity of Action

Alessandro Bonardi, Alessio Nocentini, Silvia Bua, Jacob Combs, Carrie Lomelino, Jacob Andring, Laura Lucarini, Silvia Sgambellone, Emanuela Masini, Robert McKenna, Paola Gratteri, Claudiu T. Supuran

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Chemistry, Medicinal

One-Pot Procedure for the Synthesis of Asymmetric Substituted Ureido Benzene Sulfonamides as Effective Inhibitors of Carbonic Anhydrase Enzymes

Gioele Vannozzi, Daniela Vullo, Andrea Angeli, Marta Ferraroni, Jacob Combs, Carrie Lomelino, Jacob Andring, Robert Mckenna, Gianluca Bartolucci, Marco Pallecchi, Laura Lucarini, Silvia Sgambellone, Emanuela Masini, Fabrizio Carta, Claudiu T. Supuran

Summary: A one-pot procedure was developed for synthesizing asymmetrical ureido-containing benzenesulfonamides, generating a library of new compounds that were evaluated for their inhibitory properties against carbonic anhydrases in vitro. The best compounds were then screened for their ability to reduce intraocular pressure in glaucomatous rabbits. X-ray crystallography was used to assess the binding modes of selected compounds.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

The three-tails approach as a new strategy to improve selectivity of action of sulphonamide inhibitors against tumour-associated carbonic anhydrase IX and XII

Alessandro Bonardi, Silvia Bua, Jacob Combs, Carrie Lomelino, Jacob Andring, Sameh Mohamed Osman, Alessandra Toti, Lorenzo Di Cesare Mannelli, Paola Gratteri, Carla Ghelardini, Robert McKenna, Alessio Nocentini, Claudiu T. Supuran

Summary: Human carbonic anhydrase isoforms IX and XII have been confirmed as anticancer targets, with three-tails approach showing higher selectivity against tumor-associated isoforms and demonstrating anti-proliferative effects in various cancer cell lines. X-ray crystallography studies have been conducted to investigate the binding mode of these inhibitors, providing valuable insights for potential cancer treatments.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)

Review Chemistry, Medicinal

Crystallography and Its Impact on Carbonic Anhydrase Research

Carrie L. Lomelino, Jacob T. Andring, Robert McKenna

INTERNATIONAL JOURNAL OF MEDICINAL CHEMISTRY (2018)

Correction Biochemistry & Molecular Biology

miR-196a provides antioxidative neuroprotection via USP15/Nrf2 regulation in Huntington's disease (vol 209, pg 292, 2023)

Siew Chin Chan, Chih-Wei Tung, Chia-Wei Lin, Yun-Shiuan Tung, Po-Min Wu, Pei-Hsun Cheng, Chuan-Mu Chen, Shang-Hsun Yang

FREE RADICAL BIOLOGY AND MEDICINE (2024)

Article Biochemistry & Molecular Biology

Ribosome-targeting antibiotic control NLRP3-mediated inflammation by inhibiting mitochondrial DNA synthesis

Suyuan Liu, Meiling Tan, Jiangxue Cai, Chenxuan Li, Miaoxin Yang, Xiaoxiao Sun, Bin He

Summary: This study reveals that the antibiotic doxycycline effectively inhibits NLRP3 inflammasome activation by targeting mitochondrial translation and mtDNA synthesis, offering potential for the treatment of NLRP3-related diseases.

FREE RADICAL BIOLOGY AND MEDICINE (2024)

Article Biochemistry & Molecular Biology

Protectin D1 inhibits TLR4 signaling pathway to alleviate non-alcoholic steatohepatitis via upregulating IRAK-M

Hao Liu, Nana Li, Ge Kuang, Xia Gong, Ting Wang, Jun Hu, Hui Du, Minxuan Zhong, Jiashi Guo, Yao Xie, Yang Xiang, Shengwang Wu, Yiling Yuan, Xinru Yin, Jingyuan Wan, Ke Li

Summary: Protectin D1 (PTD1) improves hepatic steatosis, inflammation and fibrosis in a NASH mouse model by inhibiting the activation of TLR4 downstream signaling pathway, possibly through upregulation of IRAK-M expression, suggesting a potential new treatment for NASH.

FREE RADICAL BIOLOGY AND MEDICINE (2024)